BIOD351 Module 8 FINAL TEST READINESS EXAM Q & S 2026/2027

BIOD351 Module 8 FINAL TEST READINESS EXAM Q & S 2026/2027
1. Multiple Choice: Which medication is considered first-line
treatment for a patient with newly diagnosed Parkinson's
disease?
 A) Ropinirole
 B) Amantadine
 C) Levodopa
 D) Selegiline
 Answer: C) Levodopa
2. Fill-in-the-Blank: The primary neurotransmitter involved in
schizophrenia is __________.
 Answer: Dopamine
3. True/False: Bipolar disorder is primarily treated with
antipsychotic medications.
 Answer: False (mood stabilizers are the first-line
treatment)
4. Multiple Response: Select all that apply. Which of the
following are common side effects of SSRIs?
 A) Dry mouth
 B) Insomnia
 C) Weight gain
 D) Hypertension
 Answers: A) Dry mouth, B) Insomnia, C) Weight gain
5. Multiple Choice: What is the mechanism of action of
benzodiazepines?
 A) Blockade of dopamine receptors
 B) Inhibition of monoamine oxidase